PRO-DRUG FORM (P2PDOX) OF THE HIGHLY POTENT 2-PYRROLINODOXORUBICIN CONJUGATED TO ANTIBODIES FOR TARGETED THERAPY OF CANCER
Disclosed are methods, compositions and uses of conjugates of prodrug forms of 2-pyrrolinodoxorubicin (P2PDox) with antibodies or antigen-binding fragments thereof (ADCs), with targetable construct peptides or with other targeting molecules that are capable of delivering the P2PDox to a targeted cel...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
21.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!